Global Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Landscape Professional Research Report 2024

Research Summary

Phosphodiesterase Type 5 (PDE5) inhibitors are a class of drugs that block the enzyme phosphodiesterase type 5, which is involved in the regulation of blood flow in the penis. By inhibiting this enzyme, PDE5 inhibitors increase the levels of cyclic guanosine monophosphate (cGMP), leading to the relaxation of smooth muscle cells and the dilation of blood vessels. This mechanism enhances blood flow to the penile tissue, thereby facilitating and maintaining an erection in response to sexual stimulation. Commonly used PDE5 inhibitors include sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra). These medications are primarily prescribed for the treatment of erectile dysfunction (ED) and, in some cases, pulmonary arterial hypertension (PAH) due to their vasodilatory effects. PDE5 inhibitors have revolutionized the management of ED, offering effective and generally well-tolerated treatment options for many men.

According to DIResearch's in-depth investigation and research, the global Phosphodiesterase Type 5 (PDE5) Inhibitor market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Phosphodiesterase Type 5 (PDE5) Inhibitor include Eli Lilly, Pfizer, Bayer, Novartis AG, Merck, GlaxoSmithKline plc, Roche, AstraZeneca, BaiYunShan General Factory, SK Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, Vectura Group etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Phosphodiesterase Type 5 (PDE5) Inhibitor. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Phosphodiesterase Type 5 (PDE5) Inhibitor market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Phosphodiesterase Type 5 (PDE5) Inhibitor market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Phosphodiesterase Type 5 (PDE5) Inhibitor industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Phosphodiesterase Type 5 (PDE5) Inhibitor Include:

Eli Lilly

Pfizer

Bayer

Novartis AG

Merck

GlaxoSmithKline plc

Roche

AstraZeneca

BaiYunShan General Factory

SK Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

Vectura Group

Phosphodiesterase Type 5 (PDE5) Inhibitor Product Segment Include:

Sildenafil

Tadalafil

Avanafil

Vardenafil

Phosphodiesterase Type 5 (PDE5) Inhibitor Product Application Include:

Hospital

Retail Pharmacy

Online Pharmacies

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Industry PESTEL Analysis

Chapter 3: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Porter's Five Forces Analysis

Chapter 4: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Major Regional Market Size and Forecast Analysis

Chapter 5: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Overview

1.1 Product Definition and Statistical Scope

1.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Product by Type

1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Sildenafil

1.2.3 Tadalafil

1.2.4 Avanafil

1.2.5 Vardenafil

1.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Product by Application

1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacies

1.3.5 Other

1.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Revenue Analysis (2019-2030)

1.5 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Development Status and Trends

1.5.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Development Status Analysis

1.5.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Development Trends Analysis

2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Analysis by Regions

4.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Overall Market: 2023 VS 2024 VS 2030

4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue and Market Share by Region (2019-2024)

4.2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Forecast by Region (2025-2030)

5 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type and Application

5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

6 North America

6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

6.5 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

7.5 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

8.4 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

9.4 APAC (excl. China) Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

9.5 APAC (excl. China) Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

10.4 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

10.5 Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type

11.4 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application

11.5 Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Revenue by Key Manufacturers (2020-2024)

12.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Landscape Analysis and Market Dynamic

12.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Pfizer

13.2.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Bayer

13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Novartis AG

13.4.1 Novartis AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Merck

13.5.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 GlaxoSmithKline plc

13.6.1 GlaxoSmithKline plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Roche

13.7.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 AstraZeneca

13.8.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 BaiYunShan General Factory

13.9.1 BaiYunShan General Factory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 SK Chemicals

13.10.1 SK Chemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Teva Pharma

13.11.1 Teva Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Dong-A ST

13.12.1 Dong-A ST Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Metuchen Pharma

13.13.1 Metuchen Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Seoul Pharma

13.14.1 Seoul Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Vectura Group

13.15.1 Vectura Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product Portfolio

13.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Chain Analysis

14.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Typical Downstream Customers

14.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support